Innovation immunomodulatory treatment - case study of men diagnosed with relapsing - remitting multiple sclerosis
Martyna Siudak , Dominika Cylke , Anna Tober-Marczewska
AbstractMultiple Sclerosis (MS) is a complex disease that interferes with environmental factors and genetically predisposed conditions. This is a chronic, inflammatory disease of the central nervous system in which demyelination of neural tissue occurs. It is most often the case for young people with a slightly higher prevalence among women than men. Occurrence is rising in countries far from the equator, and the highest incidence is observed in temperate white people. This disease is characterized by so-called "rolls" that can last from 24 hours to several weeks. At this time there is a sudden increase in the existing symptoms or the appearance of a new one. The first signs of the disease are often mild and tend to cease quickly. The name reflects the spread of the pathological process in various places in the nervous system as well as the spread of changes over time. Regardless of the recognized form, the effect of MS is disability and reduced quality of life, which hinders self-reliance, self-care and freedom of movement. This paper is a case study of 49-year-old patient diagnosed with relapsing-remitting MS included in the experimental program of immunomodulatory treatment.
|Journal series||World Scientific News, ISSN , e-ISSN 2392-2192, (B 6 pkt)|
|Publication size in sheets||0.5|
|Keywords in English||sclerosis multiplex, SM, immunomodulatory, treatment, disability, experimental|
|License||Journal (articles only); published final; ; with publication|
|Score|| = 6.0, 15-01-2018, ArticleFromJournal|
= 6.0, 15-01-2018, ArticleFromJournal
* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.